@orbitalmayo You gotta look at phase II trials, as outlined in the study, not just phase I:
"[In] Phase II the success rate is ∼40%, albeit on a limited sample size, comparable to historic industry averages."
(Phase II studies determine the effectiveness of an experimental drug on a particular disease or condition in approximately 100 to 300 volunteers.)